238 related articles for article (PubMed ID: 35483554)
1. Development of a smartphone-based quantum dot lateral flow immunoassay strip for ultrasensitive detection of anti-SARS-CoV-2 IgG and neutralizing antibodies.
Li J; Liu B; Tang X; Wu Z; Lu J; Liang C; Hou S; Zhang L; Li T; Zhao W; Fu Y; Ke Y; Li C
Int J Infect Dis; 2022 Aug; 121():58-65. PubMed ID: 35483554
[TBL] [Abstract][Full Text] [Related]
2. Development of a quantum dot-based lateral flow immunoassay strip for rapid and sensitive detection of SARS-CoV-2 neutralizing antibodies.
Wang X; Shao S; Ye H; Li S; Gu B; Tang B
Sci Rep; 2023 Dec; 13(1):22253. PubMed ID: 38097611
[TBL] [Abstract][Full Text] [Related]
3. Sensitive and Simultaneous Detection of SARS-CoV-2-Specific IgM/IgG Using Lateral Flow Immunoassay Based on Dual-Mode Quantum Dot Nanobeads.
Wang C; Yang X; Gu B; Liu H; Zhou Z; Shi L; Cheng X; Wang S
Anal Chem; 2020 Dec; 92(23):15542-15549. PubMed ID: 33207872
[TBL] [Abstract][Full Text] [Related]
4. Validation of a quantitative lateral flow immunoassay (LFIA)-based point-of-care (POC) rapid test for SARS-CoV-2 neutralizing antibodies.
Pieri M; Nicolai E; Nuccetelli M; Sarubbi S; Tomassetti F; Pelagalli M; Minieri M; Terrinoni A; Bernardini S
Arch Virol; 2022 May; 167(5):1285-1291. PubMed ID: 35377034
[TBL] [Abstract][Full Text] [Related]
5. Latex Microsphere-Based Bicolor Immunochromatography for Qualitative Detection of Neutralizing Antibody against SARS-CoV-2.
Liang Z; Peng T; Jiao X; Zhao Y; Xie J; Jiang Y; Meng B; Fang X; Yu X; Dai X
Biosensors (Basel); 2022 Feb; 12(2):. PubMed ID: 35200362
[TBL] [Abstract][Full Text] [Related]
6. Development of receptor binding domain-based double-antigen sandwich lateral flow immunoassay for the detection and evaluation of SARS-CoV-2 neutralizing antibody in clinical sera samples compared with the conventional virus neutralization test.
Zhang Y; Chen Y; He Y; Li Y; Zhang X; Liang J; He J; Lu S; Gao Z; Xu J; Tang Y
Talanta; 2023 Apr; 255():124200. PubMed ID: 36565525
[TBL] [Abstract][Full Text] [Related]
7. Detection of SARS-CoV-2 Neutralizing Antibodies in Vaccinated Pregnant Women and Neonates by Using a Lateral Flow Immunoassay Coupled with a Spectrum-Based Reader.
Chen WC; Lin YP; Cheng CM; Shen CF; Li CW; Wang YK; Shih TY; Hong C; Chang TC; Shen CJ
Biosensors (Basel); 2022 Oct; 12(10):. PubMed ID: 36291029
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
[TBL] [Abstract][Full Text] [Related]
9. Ultrasensitive and Simultaneous Detection of Two Specific SARS-CoV-2 Antigens in Human Specimens Using Direct/Enrichment Dual-Mode Fluorescence Lateral Flow Immunoassay.
Wang C; Cheng X; Liu L; Zhang X; Yang X; Zheng S; Rong Z; Wang S
ACS Appl Mater Interfaces; 2021 Sep; 13(34):40342-40353. PubMed ID: 34412466
[TBL] [Abstract][Full Text] [Related]
10. Technical performance of a lateral flow immunoassay for detection of anti-SARS-CoV-2 IgG in the outpatient follow-up of non-severe cases and at different times after vaccination: comparison with enzyme and chemiluminescent immunoassays.
Barreira GA; Santos EHD; Pereira MFB; Rodrigues KA; Rocha MC; Kanunfre KA; Marques HHS; Okay TS; ; Eisencraft AP; Rossi Junior A; Fante AL; Cora AP; Costa Reis AGA; Ferrer APS; Andrade APM; Watanabe A; Gonçalves AMF; Waetge ARP; Silva CA; Ceneviva C; Lazari CDS; Abellan DM; Sabino EC; Bianchini FRM; Alcantara FFP; Ramos GF; Leal GN; Rodriguez IS; Pinho JRR; Carneiro JDA; Paz JA; Ferreira JC; Ferranti JF; Ferreira JOA; Framil JVS; Silva KRD; Bastos KLM; Galleti KV; Cristofani LM; Suzuki L; Campos LMA; Perondi MBM; Diniz MFR; Fonseca MFM; Cordon MNA; Pissolato M; Peres MS; Garanito MP; Imamura M; Dorna MB; Luglio M; Aikawa NE; Degaspare NV; Sakita NK; Udsen NL; Scudeller PG; Gaiolla PVV; Severini RDSG; Rodrigues RM; Toma RK; Paula RIC; Palmeira P; Forsait S; Farhat SCL; Sakano TMS; Koch VHK; Cobello Junior V
Rev Inst Med Trop Sao Paulo; 2022; 64():e49. PubMed ID: 35858039
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal profile of neutralizing and binding antibodies in vaccinated and convalescent COVID-19 cohorts by chemiluminescent immunoassays.
Dou X; Wang E; Jiang R; Li M; Xiong D; Sun B; Zhang X
Immun Inflamm Dis; 2022 Jun; 10(6):e612. PubMed ID: 35634960
[TBL] [Abstract][Full Text] [Related]
12. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891
[TBL] [Abstract][Full Text] [Related]
13. Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects.
Zhang P; Li B; Wang Y; Min W; Wang X; Zhou Y; Li Z; Zhao Y; Zhang H; Jiang M; Zheng H; Yang C; Zhang W; Zuo L; Gao Q; Yang Z; Li Y; Feng T; Lin C; Hu Q; Song T; Yang R
BMC Microbiol; 2022 Feb; 22(1):42. PubMed ID: 35114938
[TBL] [Abstract][Full Text] [Related]
14. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
15. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
[TBL] [Abstract][Full Text] [Related]
16. The instantly blocking-based fluorescent immunochromatographic assay for the detection of SARS-CoV-2 neutralizing antibody.
Li Y; He J; Zhang Y; Liang D; Zhang J; Ji R; Wu Y; Su Z; Ke C; Xu N; Tang Y; Xu J
Front Cell Infect Microbiol; 2023; 13():1203625. PubMed ID: 37736103
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of a SARS-CoV-2 Rapid Test Kit for Detection of Neutralizing Antibodies as a Point-of-Care Surveillance Test.
Chan MMH; Leung KY; Zhang RRQ; Liu D; Fan Y; Khong MKW; Tam AR; Chen H; Yuen KY; Hung IFN; Chan KH
Microbiol Spectr; 2022 Apr; 10(2):e0099321. PubMed ID: 35254121
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the IgG antibody response to SARS CoV-2 infection and performance of a lateral flow immunoassay: cross-sectional and longitudinal analysis over 11 months.
Robertson LJ; Moore JS; Blighe K; Ng KY; Quinn N; Jennings F; Warnock G; Sharpe P; Clarke M; Maguire K; Rainey S; Price RK; Burns WP; Kowalczyk AM; Awuah A; McNamee SE; Wallace GE; Hunter D; Sager S; Chao Shern C; Nesbit MA; McLaughlin JAD; Moore T
BMJ Open; 2021 Jun; 11(6):e048142. PubMed ID: 34187827
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Kinetics of SARS-CoV-2 Antibodies and Impact of Inactivated Vaccine on SARS-CoV-2 Antibodies Based on a COVID-19 Patients Cohort.
Zhang S; Xu K; Li C; Zhou L; Kong X; Peng J; Zhu F; Bao C; Jin H; Gao Q; Zhao X; Zhu L
Front Immunol; 2022; 13():829665. PubMed ID: 35154152
[TBL] [Abstract][Full Text] [Related]
20. A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2).
Lee JH; Choi M; Jung Y; Lee SK; Lee CS; Kim J; Kim J; Kim NH; Kim BT; Kim HG
Biosens Bioelectron; 2021 Jan; 171():112715. PubMed ID: 33099241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
